Condition: Coronary Artery Disease · Chronic Stable Angina · Unstable Angina · Sponsor: Biosensors Europe SA
This study aims to demonstrate that the BioFreedom™ Ultra Drug Coated Stent (DCS) is non-inferior to the BioFreedom™ DCS, with respect to in-stent late lumen loss, and that it has safety characteristics similar to the BioFreedom™ DCS.
This description comes directly from the study's public registry record.
Kar Imm Ang, MSc. · +65 6213 0142 · ki.ang@biosensors.com
Always discuss trial participation with your own doctor first.
| Hospital Sultanah Aminah | Johor Bahru, Johor, Malaysia | Recruiting |
| Hospital Tengku Ampuan Afzan | Kuantan, Pahang, Malaysia | Recruiting |
| Hospital Raja Permaisuri Bainun | Ipoh, Perak, Malaysia | Recruiting |
| Hospital Queen Elizabeth II | Kota Kinabalu, Sabah, Malaysia | Recruiting |
| Pusat Jantung Hospital Umum Sarawak | Kota Kinabalu, Sarawak, Malaysia | Recruiting |
| Hospital Serdang | Kajang, Selangor, Malaysia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06657326